Tiagabine appears not to be efficacious in the treatment of acute mania

被引:62
作者
Grunze, H
Erfurth, A
Marcuse, A
Amann, B
Normann, C
Walden, J
机构
[1] Univ Munich, Psychiat Klin, Dept Psychiat, D-80336 Munich, Germany
[2] Univ Freiburg, Dept Psychiat, Freiburg, Germany
关键词
D O I
10.4088/JCP.v60n1107
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Because a GABAergic hypofunction has been implied in the pathophysiology of mania, we have tested the antimanic properties of the GABA transporter 1 inhibitor tiagabine. Method: An open trial was conducted in 8 acutely manic inpatients with DSM-IV bipolar I disorder, 2 of them with tiagabine monotherapy and 6 with tiagabine as an add-on to previously insufficient mood-stabilizing medication. The study duration was 14 days. Changes in psychopathology were assessed by the Bech-Rafaelsen Mania Rating Scale. Results: None of the patients showed clear-cut relief from manic symptoms during the 2-week observation period. In 2 patients, we saw pronounced side effects (nausea and vomiting in one and a generalized tonic-clonic seizure in the other). Conclusion: The results from this open trial suggest that tiagabine seems to have no pronounced antimanic efficacy compared with standard treatments such as valproate, lithium, or neuroleptics. It also appears that rapid dosage increases for antimanic treatment can cause potentially severe side effects.
引用
收藏
页码:759 / 762
页数:4
相关论文
共 23 条
[1]   MANIA RATING-SCALE - SCALE CONSTRUCTION AND INTER-OBSERVER AGREEMENT [J].
BECH, P ;
RAFAELSEN, OJ ;
KRAMP, P ;
BOLWIG, TG .
NEUROPHARMACOLOGY, 1978, 17 (06) :430-431
[2]  
BRODIE MJ, 1995, EPILIPSIA, V36, P7
[3]  
Calabrese JR, 1996, AM J PSYCHIAT, V153, P759
[4]  
Dalby NO, 1997, NEUROSCI LETT, V229, P135
[5]   Nonconvulsive status epilepticus in two patients receiving tiagabine treatment [J].
Eckardt, KM ;
Steinhoff, BJ .
EPILEPSIA, 1998, 39 (06) :671-674
[6]  
Emrich H M, 1981, Adv Biochem Psychopharmacol, V26, P287
[7]   VALPROATE TREATMENT OF MANIA [J].
EMRICH, HM ;
WOLF, R .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1992, 16 (05) :691-701
[8]  
GERNER RH, 1984, AM J PSYCHIAT, V141, P1533
[9]  
Hu RQ, 1997, BRAIN RES, V753, P260
[10]  
Kaufman K R, 1998, Ann Clin Psychiatry, V10, P181, DOI 10.1023/A:1022350330567